Vetter Introduces Updated Syringe Closure System

It's scheduled for launch in 2027.

Vetter Introduces The Next Evolution Of The V Ovs Syringe Closure System
Vetter

Contract manufacturer Vetter announced the development and upcoming launch of the new version of its proprietary V-OVS syringe closure system.

This latest evolution will integrate several technical advances guided by both shifting market needs and feedback from the many customers who have selected V-OVS for their products. Similar to the original system, the design of V-OVS next will be optimized to protect the integrity of the injectable product secured by the closure. For customers with products in glass-barrel syringes, this new closure will be an opportunity to integrate gold-standard Luer Lock features with easier handling characteristics and a more intuitive opening mechanism.

While still in development, Vetter has already placed V-OVS next on a launch pathway for 2027. For now, the focus remains on finalizing the system’s design and further advancing its commercialization. As part of its go-to-market preparations, Vetter recently conducted a successful human factors study with a representative group of frontline clinical users. The study delivered consistent positive feedback and insights that will directly contribute to finalizing the design of the new closure system.

Post-launch, Vetter will continue to offer both V-OVS and V-OVS next, expanding its portfolio to offer customers more options for their syringe-based products.

More in Equipment